NLM Logo

epratuzumab MeSH Supplementary Concept Data 2023


MeSH Supplementary
epratuzumab
Unique ID
C448700
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C448700
Entry Term(s)
AMG-412
HLL2
IMMU-HLL2
LymphoCide
hLL2 agent
Pharm Action
Antineoplastic Agents, Immunological
Registry Number
3062P60MH9
Previous Indexing
*ANTIBODIES, MONOCLONAL (2002-2011)
*ANTINEOPLASTIC AGENTS (2002-2003)
Heading Mapped to
*Antibodies, Monoclonal, Humanized
Frequency
145
Source
Semin Oncol 2002 Feb;29(1 Suppl 2):81-6
Date of Entry
2002/03/06
Revision Date
2019/10/31
epratuzumab Preferred
LymphoCide Narrower
HLL2 Narrower
AMG-412 Narrower
page delivered in 0.003s